All persons or entities that purchased or otherwise acquired the publicly-traded securities of Cocrystal Pharma, Inc. (“Cocrystal”) and/or BioZone Pharmaceuticals, Inc. (“BioZone”) during the period between September 23, 2013 and September 7, 2018, both dates inclusive
Disbursed
September 23, 2013 - December 07, 2018
December 16, 2020
November 25, 2020
Strategic Claims Services
Cocrystal Pharma, Inc. Securities Litigation c/o Strategic Claims Services 600 N. Jackson St., Ste. 205 P.O. Box 230 Media, PA 19063
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.